BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Levitsky J, Asrani SK, Abecassis M, Ruiz R, Jennings LW, Klintmalm G. External Validation of a Pretransplant Biomarker Model (REVERSE) Predictive of Renal Recovery After Liver Transplantation. Hepatology 2019;70:1349-59. [DOI: 10.1002/hep.30667] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Allegretti AS, Solà E, Ginès P. Clinical Application of Kidney Biomarkers in Cirrhosis. American Journal of Kidney Diseases 2020;76:710-9. [DOI: 10.1053/j.ajkd.2020.03.016] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
2 Mathew JM, Leventhal JR. Cell therapy can enable minimization of immunosuppression. Nat Rev Nephrol 2020;16:486-7. [PMID: 32690966 DOI: 10.1038/s41581-020-0330-5] [Reference Citation Analysis]
3 Levitsky J, Asrani SK, Klintmalm G, Schiano T, Moss A, Chavin K, Miller C, Guo K, Zhao L, Jennings LW, Brown M, Armstrong B, Abecassis M. Discovery and Validation of a Biomarker Model (PRESERVE) Predictive of Renal Outcomes After Liver Transplantation. Hepatology 2020;71:1775-86. [PMID: 31509263 DOI: 10.1002/hep.30939] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
4 Nilles KM, Levitsky J. Current and Evolving Indications for Simultaneous Liver Kidney Transplantation. Semin Liver Dis 2021;41:308-20. [PMID: 34130337 DOI: 10.1055/s-0041-1729969] [Reference Citation Analysis]
5 Asrani SK, Levitsky J. Mission accomplished? Early data from the simultaneous liver-kidney transplantation allocation policy. Am J Transplant 2021. [PMID: 34375502 DOI: 10.1111/ajt.16796] [Reference Citation Analysis]
6 Levitsky J, Asrani SK, Schiano T, Moss A, Chavin K, Miller C, Guo K, Zhao L, Kandpal M, Bridges N, Brown M, Armstrong B, Kurian S, Demetris AJ, Abecassis M; Clinical Trials in Organ Transplantation - 14 Consortium. Discovery and validation of a novel blood-based molecular biomarker of rejection following liver transplantation. Am J Transplant 2020;20:2173-83. [PMID: 32356368 DOI: 10.1111/ajt.15953] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
7 Khemichian S, Francoz C, Nadim MK. Advances in management of hepatorenal syndrome. Curr Opin Nephrol Hypertens 2021;30:501-6. [PMID: 34397647 DOI: 10.1097/MNH.0000000000000730] [Reference Citation Analysis]
8 Morelli MC, Rendina M, La Manna G, Alessandria C, Pasulo L, Lenci I, Bhoori S, Messa P, Biancone L, Gesualdo L, Russo FP, Petta S, Burra P; Italian Association for the Study of Liver, and the Italian Society of Nephrology. Position paper on liver and kidney diseases from the Italian Association for the Study of Liver (AISF), in collaboration with the Italian Society of Nephrology (SIN). Dig Liver Dis 2021;53 Suppl 2:S49-86. [PMID: 34074490 DOI: 10.1016/j.dld.2021.03.035] [Cited by in F6Publishing: 1] [Reference Citation Analysis]